Implantable Cardioverter Defibrillators Market: Global Analysis of Key Manufacturers, Dynamics & Forecast 2024-2032

1
Implantable Cardioverter Defibrillators Market
with Report In Depth Industry Analysis on Trends,
Growth, Opportunities and Forecast till 2032
2

• Industry Insights

• Implantable cardioverter defibrillators market
  size is projected to expand at over 6.4 from
  2024 to 2032.
• The increasing prevalence of cardiovascular
  diseases, especially arrhythmias and sudden
  cardiac arrests is fueling the demand for
  implantable cardioverter defibrillators (ICDs).
• The aging population and growing
  lifestyle-related risk factors is leading to
  rising advancements in ICD technology.
• For instance, in December 2024, the PROFID EHRA
  study was launched, representing the first
  clinical trial for reevaluating the standard
  practice of implanting defibrillators in heart
  attack survivors with heart failure.
• The rising awareness about preventive healthcare
  measures coupled with the influx of favorable
  reimbursement policies will stimulate the
  adoption of implantable cardioverter
  defibrillators.

3

• The ongoing RD activities, including the
  integration of remote monitoring and leadless
  devices is further enhancing the product
  effectiveness and accessibility.
• Additionally, strategic collaborations between
  healthcare providers and device manufacturers
  along with the increasing regulatory support for
  innovative cardiac solutions will complement the
  industry expansion.
• Based on product type, the industry share from
  the subcutaneous ICDs segment is projected to
  rise at 6.9 CAGR from 2024 to 2032.
• The growth can be ascribed to the increasing
  preference for subcutaneous implantable
  cardioverter defibrillators (S-ICDs) due to their
  minimally invasive nature.
• The reduced infection risk, improved patient
  comfort, and increasing advancements in S-ICD
  technology will drive the product adoption in the
  management of life-threatening cardiac
  arrhythmias.
• Implantable cardioverter defibrillators industry
  size from the dual-chamber ICDs type segment is
  estimated to expand at 7 CAGR between 2024 and
  2032, owing to the increasing demand for
  sophisticated arrhythmia management.

4

• Regional Analysis

• Regionally, the Europe implantable cardioverter
  defibrillators industry size will depict 6.1
  CAGR between 2024 and 2032. The growth can be
  attributed to the aging population, increasing
  incidence of cardiovascular diseases, and the
  higher technological advancements in cardiac
  devices. Moreover, the introduction of supportive
  healthcare policies, the rising awareness of
  preventive cardiology, and strategic
  collaborations between healthcare organizations
  and device manufacturers will drive the industry
  expansion across the region.

• Competitive Analysis

• BIOTRONIK SE Co. KG
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• LivaNova plc
• FUKUDA DENSHI CO. Ltd
• IMRICOR MEDICAL SYSTEMS
• Koninklijke Philips N.V
• Nohen Kohden Corporation
• CU Medical Germany GmbH
• MEDIANA Co., Ltd.

5
Implantable Cardioverter Defibrillators Market _at_
https//www.gminsights.com/industry-analysis/impla
ntable-cardioverter-defibrillators-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/7
696
Request for customization _at_ https//www.gminsights
.com/roc/7696
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com